PEDEVCO CORP. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by PEDEVCO CORP. on January 26, 2024. The filing discloses corporate actions taken in connection with the Company's 2023 annual compensation review, specifically regarding equity awards and salary adjustments for executive officers and certain employees.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. The financial data presented is limited to specific compensation figures:
- Restricted Stock Issued: 2,105,000 shares total.
- Stock Options Issued: 460,000 options with an exercise price of $0.6675 per share.
- Salary Increases: Approved for three officers, effective February 1, 2024.
- Cash Bonuses: Total of $265,000 approved for three officers.
Material Changes
The primary material change reported is the approval and issuance of equity and cash compensation under the 2021 Equity Incentive Plan. Specific changes include:
- Equity Grants:
- CEO Dr. Simon G. Kukes: 550,000 restricted shares.
- President Mr. J. Douglas Schick: 525,000 restricted shares.
- EVP/General Counsel Mr. Clark R. Moore: 450,000 restricted shares.
- CFO Mr. Paul Pinkston: 250,000 restricted shares.
- Other non-executive employees: 330,000 restricted shares and 460,000 stock options.
- Compensation Adjustments:
- Mr. Paul Pinkston: Base salary increased from $160,000 to $168,000 (5%); $35,000 cash bonus.
- Mr. J. Douglas Schick: Base salary increased from $290,000 to $304,500 (5%); $120,000 cash bonus.
- Mr. Clark R. Moore: Base salary increased from $280,000 to $294,000 (5%); $110,000 cash bonus.
Outlook, Risks, and Unusual Items
The filing does not contain forward-looking guidance, risk factors, or unusual items beyond the standard vesting conditions for the equity awards. All restricted stock and options are subject to "Three Year Vesting Terms" (1/3 vesting annually over three years) contingent upon the recipient's continued service to the Company.
Investor Verification Checklist
- Verify the total number of shares outstanding post-issuance to assess dilution impact.
- Review the full text of the Restricted Shares Grant Agreement (Exhibit 10.2) and Stock Option Grant Agreement (Exhibit 10.3) for specific forfeiture clauses or performance conditions not detailed in the summary.
- Confirm the Company's cash position to ensure it can fund the $265,000 in approved cash bonuses.
- Check subsequent filings for any changes to the vesting schedule or executive departures that would trigger forfeiture.